• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6-硫鸟嘌呤的细胞毒性机制:hMutSalpha,即人类错配结合异二聚体,可与含有S6-甲基硫鸟嘌呤的DNA结合。

Cytotoxic mechanism of 6-thioguanine: hMutSalpha, the human mismatch binding heterodimer, binds to DNA containing S6-methylthioguanine.

作者信息

Waters T R, Swann P F

机构信息

Department of Biochemistry and Molecular Biology, University College London, U.K.

出版信息

Biochemistry. 1997 Mar 4;36(9):2501-6. doi: 10.1021/bi9621573.

DOI:10.1021/bi9621573
PMID:9054555
Abstract

It has been suggested that the cytotoxicity of 6-thioguanine depends upon (1) incorporation of 6-thioguanine into DNA, (2) methylation by S-adenosylmethionine (SAM) of the thio group to give S6-methylthioguanine, (3) miscoding during DNA replication to give [SMeG] x T base pairs, and (4) recognition of these base pairs by proteins of the postreplicative mismatch repair system. Here we have investigated systematically the ability of proteins present in human cell extracts to bind to DNA containing S6-methylthioguanine. We found that [SMeG] x T base mismatches were bound by the mismatch binding complex, hMutS alpha, and that the level of binding was dependent upon the base 5' to the S6-methylthioguanine in the order G > C = A > T. Extracts from cells that lack either hMSH2 (LoVo cells) or GTBP (HCT-15 cells), two components of the hMutS alpha complex, were unable to bind the [SMeG] x T base pair. We also found that hMutS alpha was able to bind to [SMeG] x C base pairs when the S6-methylthioguanine was in the sequence 5'-Cp[SMeG]. This suggests that miscoding by S6-methylthioguanine residues in DNA during DNA synthesis may not be an absolutely required step in the mechanism of cytotoxicity. Also, since CpG sequences are so important in gene regulation, this result may be of considerable significance.

摘要

有人提出,6-硫鸟嘌呤的细胞毒性取决于:(1)6-硫鸟嘌呤掺入DNA;(2)硫基团被S-腺苷甲硫氨酸(SAM)甲基化生成S6-甲基硫鸟嘌呤;(3)DNA复制过程中的错配编码生成[SMeG]×T碱基对;(4)复制后错配修复系统的蛋白质对这些碱基对的识别。在此,我们系统地研究了人细胞提取物中存在的蛋白质与含有S6-甲基硫鸟嘌呤的DNA结合的能力。我们发现,[SMeG]×T碱基错配被错配结合复合物hMutSα结合,且结合水平取决于S6-甲基硫鸟嘌呤5'端的碱基,顺序为G>C = A>T。缺乏hMutSα复合物的两个组分hMSH2(LoVo细胞)或GTBP(HCT-15细胞)的细胞提取物无法结合[SMeG]×T碱基对。我们还发现,当S6-甲基硫鸟嘌呤位于5'-Cp[SMeG]序列中时,hMutSα能够结合[SMeG]×C碱基对。这表明DNA合成过程中DNA中S6-甲基硫鸟嘌呤残基的错配编码可能不是细胞毒性机制中绝对必需的步骤。此外,由于CpG序列在基因调控中非常重要,这一结果可能具有相当重要的意义。

相似文献

1
Cytotoxic mechanism of 6-thioguanine: hMutSalpha, the human mismatch binding heterodimer, binds to DNA containing S6-methylthioguanine.6-硫鸟嘌呤的细胞毒性机制:hMutSalpha,即人类错配结合异二聚体,可与含有S6-甲基硫鸟嘌呤的DNA结合。
Biochemistry. 1997 Mar 4;36(9):2501-6. doi: 10.1021/bi9621573.
2
Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine.复制后DNA错配修复在硫鸟嘌呤细胞毒性作用中的作用。
Science. 1996 Aug 23;273(5278):1109-11. doi: 10.1126/science.273.5278.1109.
3
Kinetics of the action of thymine DNA glycosylase.胸腺嘧啶DNA糖基化酶的作用动力学
J Biol Chem. 1998 Aug 7;273(32):20007-14. doi: 10.1074/jbc.273.32.20007.
4
hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha.人源错配修复蛋白hMSH2和hMSH6在错配结合中发挥不同作用,对人源错配修复蛋白hMutSα的ATP酶活性贡献也不同。
EMBO J. 1998 May 1;17(9):2677-86. doi: 10.1093/emboj/17.9.2677.
5
Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.一种能将DNA错配修复功能恢复至肿瘤细胞的hMSH2-p160异二聚体的分离。
Science. 1995 Jun 30;268(5219):1909-12. doi: 10.1126/science.7604264.
6
DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage.哺乳动物细胞提取物对修饰鸟嘌呤碱基的DNA错配结合与切割:对DNA甲基化损伤耐受性的影响
Biochemistry. 1994 Apr 26;33(16):4787-93. doi: 10.1021/bi00182a006.
7
LC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine.LC-MS/MS 结合稳定同位素稀释法测定经 6-硫代鸟嘌呤处理的人癌细胞基因组 DNA 中 6-硫代鸟嘌呤和 S(6)-甲基硫代鸟嘌呤的含量。
Anal Chem. 2010 Jul 1;82(13):5797-803. doi: 10.1021/ac1008628.
8
The syntheses and properties of tricyclic pyrrolo[2,3-d]pyrimidine analogues of S6-methylthioguanine and O6-methylguanine.S6-甲基硫代鸟嘌呤和O6-甲基鸟嘌呤的三环吡咯并[2,3-d]嘧啶类似物的合成与性质
Org Biomol Chem. 2006 May 7;4(9):1723-9. doi: 10.1039/b516447h. Epub 2006 Mar 23.
9
Effect of 6-thioguanine on the stability of duplex DNA.6-硫鸟嘌呤对双链DNA稳定性的影响。
Nucleic Acids Res. 2005 May 19;33(9):2880-6. doi: 10.1093/nar/gki572. Print 2005.
10
6-Thioguanine and S⁶-methylthioguanine are mutagenic in human cells.6-硫代鸟嘌呤和 S⁶-甲基硫代鸟嘌呤在人体细胞中具有诱变作用。
ACS Chem Biol. 2010 Nov 19;5(11):1021-7. doi: 10.1021/cb100214b.

引用本文的文献

1
The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer.O6-甲基鸟嘌呤-DNA甲基转移酶的多功能特性:其修复机制、与其他DNA修复途径的相互作用及其在癌症中的作用
Cancers (Basel). 2024 Jan 11;16(2):331. doi: 10.3390/cancers16020331.
2
Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia.靶向 DNA 聚合酶 β 可在急性淋巴细胞白血病中引起与错配修复缺陷的合成致死作用。
Leukemia. 2023 Jun;37(6):1204-1215. doi: 10.1038/s41375-023-01902-3. Epub 2023 Apr 24.
3
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.
复发急性淋巴细胞白血病化疗耐药机制的突变和功能遗传学定位。
Nat Cancer. 2020 Nov;1(11):1113-1127. doi: 10.1038/s43018-020-00124-1. Epub 2020 Oct 19.
4
Dynamics of leucocyte DNA thioguanine nucleotide levels during maintenance therapy of childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病维持治疗期间白细胞 DNA 硫鸟嘌呤核苷酸水平的动态变化。
Cancer Chemother Pharmacol. 2021 Jul;88(1):53-60. doi: 10.1007/s00280-020-04219-5. Epub 2021 Mar 23.
5
Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.儿童急性淋巴细胞白血病中口服 6-巯基嘌呤片剂和口服液体制剂的药代动力学。
Cancer Chemother Pharmacol. 2020 Jul;86(1):25-32. doi: 10.1007/s00280-020-04097-x. Epub 2020 Jun 9.
6
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours.BRCA 缺陷型肿瘤患者中巯嘌呤(6MP)和甲氨蝶呤的 II 期临床试验结果。
Br J Cancer. 2020 Feb;122(4):483-490. doi: 10.1038/s41416-019-0674-4. Epub 2019 Dec 9.
7
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.在小儿 B 淋巴细胞白血病缓解期 MSH6 杂合性缺失导致巯嘌呤耐药的发生。
Haematologica. 2018 May;103(5):830-839. doi: 10.3324/haematol.2017.176362. Epub 2018 Feb 15.
8
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients.液相色谱-质谱联用技术用于测定硫嘌呤治疗患者DNA中的脱氧硫鸟苷。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:175-180. doi: 10.1016/j.jchromb.2016.06.017. Epub 2016 Jun 15.
9
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.硫嘌呤类药物全身暴露与儿童急性淋巴细胞白血病复发风险:儿童肿瘤学组研究。
JAMA Oncol. 2015 Jun;1(3):287-95. doi: 10.1001/jamaoncol.2015.0245.
10
The Krüppel-associated box repressor domain induces reversible and irreversible regulation of endogenous mouse genes by mediating different chromatin states.Krüppel相关盒抑制结构域通过介导不同的染色质状态对内源小鼠基因进行可逆和不可逆调控。
Nucleic Acids Res. 2015 Feb 18;43(3):1549-61. doi: 10.1093/nar/gkv016. Epub 2015 Jan 21.